Li-S Energy celebrates market debut
Based on research at Deakin University, Li-S Energy has gone public on the Australian Stock Exchange after raising $25m in its initial public offering.
Lucid Diagnostics lines up IPO
Case Western Reserve University-linked Lucid Diagnostics is seeking an initial public offering that would net it up to $57.5m.
Oxford Nanopore sets IPO plans in motion
Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.
Context Therapeutics frames IPO plans
Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.
Exscientia explores Nasdaq IPO
Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.
Icosavax lands on $182m IPO
UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.
Tenaya tends to $180m IPO
The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.
IN8Bio initiates $40m IPO
IN8Bio, a University of Alabama spinout and cancer immunotherapy developer, has pulled in $40m through its IPO.
Duolingo brings in $521m IPO
Carnegie Mellon-linked Duolingo raised $521m in an upsized offering and saw its shares rise 36% on their first day.